Kivity S, Fireman E, Schwarz Y, Peer G, Agami O, Iaina A
Institute of Pulmonary and Allergy Diseases, Tel Aviv Medical Center, Israel.
Inflamm Res. 1997 Oct;46(10):404-6. doi: 10.1007/s000110050211.
Naloxone had been shown to be effective in relieving pruritus of dialyzed patients. In order to determine the mechanism by which this is accomplished, we studied its effect on histamine release from white blood cells taken from this group.
We compared 12 dialyzed patients (before and after dialysis) and 12 healthy controls.
The effect of naloxone (5 x 10(-3) M) on histamine release from the subjects' white blood cells was measured following anti-IgE + IL3 and TPA administration.
The white blood cells of dialyzed patients had a high degree of histamine release compared to the healthy controls. Neither dialysis nor the patient's plasma affected this release. Naloxone markedly inhibited histamine release from white blood cells when stimulated with anti-IgE + IL3 or with TPA.
We concluded that naloxone may have a beneficial effect in treating dialyzed patients suffering from pruritus, probably by inhibiting histamine release.
已证明纳洛酮在缓解透析患者瘙痒方面有效。为确定其作用机制,我们研究了它对该组患者白细胞组胺释放的影响。
我们比较了12名透析患者(透析前后)和12名健康对照者。
在给予抗IgE + IL3和佛波酯后,测定纳洛酮(5×10⁻³ M)对受试者白细胞组胺释放的影响。
与健康对照者相比,透析患者的白细胞组胺释放程度较高。透析及患者血浆均不影响这种释放。当用抗IgE + IL3或佛波酯刺激时,纳洛酮显著抑制白细胞组胺释放。
我们得出结论,纳洛酮可能对治疗患有瘙痒的透析患者有有益作用,可能是通过抑制组胺释放。